Immune Cell Infiltration Types as Biomarkers for the Recurrence Diagnosis and Prognosis of Bladder Cancer

被引:2
作者
Xu, Hongwei [1 ]
Sun, Dapeng [1 ]
Zhou, Dahong [1 ]
Sun, Shiheng [1 ,2 ]
机构
[1] Heilongjiang Prov Hosp, Dept Geriatr Neurol, Harbin, Heilongjiang, Peoples R China
[2] Heilongjiang Prov Hosp, Urol Dept, No 82 zhongshan Rd, Harbin, Heilongjiang, Peoples R China
关键词
Bladder cancer; recurrence; immune infiltration; prognostic model; ONCOLOGIC OUTCOMES; EXPRESSION; RISK; SURVIVAL; PREDICTION; CARCINOMA; INNATE; PD-L1;
D O I
10.1080/07357907.2024.2308161
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study aimed to investigate the role of infiltrating immune cell types in diagnosing and predicting bladder cancer recurrence. This study mainly applied some algorithms, including Estimate the Proportion of Immune and Cancer Cells (EPIC), support vector machine-recursive feature elimination (SVM-RFE), random forest out-of-bag (RF-OOB) and least absolute shrinkage and selection operator (LASSO)-Cox regression analysis. We found six immune infiltrating cell types significantly associated with recurrence prognosis and two independent clinical prognostic factors. Infiltrating immune cell types (IICTs) based on the prognostic immune risk score (pIRS) models may provide significant biomarkers for the diagnosis and prognostic prediction of bladder cancer recurrence.
引用
收藏
页码:186 / 198
页数:13
相关论文
共 62 条
[1]   THYROID FOLLICULAR CARCINOMA WITH PULMONARY METASTASES IN A BEAVER (CASTOR-CANADENSIS) [J].
ANDERSON, WI ;
SCHLAFER, DH ;
VESELY, KR .
JOURNAL OF WILDLIFE DISEASES, 1989, 25 (04) :599-600
[2]   Bladder Tumor Infiltrating Mature Dendritic Cells and Macrophages as Predictors of Response to Bacillus Calmette-Guerin Immunotherapy [J].
Ayari, Cherifa ;
LaRue, Helene ;
Hovington, Helene ;
Decobert, Marc ;
Harel, Francois ;
Bergeron, Alain ;
Tetu, Bernard ;
Lacombe, Louis ;
Fradet, Yves .
EUROPEAN UROLOGY, 2009, 55 (06) :1386-1396
[3]   European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ) [J].
Babjuk, Marko ;
Burger, Maximilian ;
Capoun, Otakar ;
Cohen, Daniel ;
Comperat, Eva M. ;
Escrig, Jose L. Dominguez ;
Gontero, Paolo ;
Liedberg, Fredrik ;
Masson-Lecomte, Alexandra ;
Mostafid, A. Hugh ;
Palou, Joan ;
van Rhijn, Bas W. G. ;
Roupret, Morgan ;
Shariat, Shahrokh F. ;
Seisen, Thomas ;
Soukup, Viktor ;
Sylvester, Richard J. .
EUROPEAN UROLOGY, 2022, 81 (01) :75-94
[4]   NCBI GEO: mining tens of millions of expression profiles - database and tools update [J].
Barrett, Tanya ;
Troup, Dennis B. ;
Wilhite, Stephen E. ;
Ledoux, Pierre ;
Rudnev, Dmitry ;
Evangelista, Carlos ;
Kim, Irene F. ;
Soboleva, Alexandra ;
Tomashevsky, Maxim ;
Edgar, Ron .
NUCLEIC ACIDS RESEARCH, 2007, 35 :D760-D765
[5]   A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now [J].
Bellmunt, Joaquin ;
Powles, Thomas ;
Vogelzang, Nicholas J. .
CANCER TREATMENT REVIEWS, 2017, 54 :58-67
[6]   Translational research in bladder cancer From molecular pathogenesis to useful tissue biomarkers [J].
Bolenz, Christian ;
Lotan, Yair .
CANCER BIOLOGY & THERAPY, 2010, 10 (05) :407-415
[7]   The Prognostic Role of Circulating Tumor Cells (CTC) in High-risk Nonemuscle-invasive Bladder Cancer [J].
Busetto, Gian Maria ;
Ferro, Matteo ;
Del Giudice, Francesco ;
Antonini, Gabriele ;
Chung, Benjamin I. ;
Sperduti, Isabella ;
Giannarelli, Diana ;
Lucarelli, Giuseppe ;
Borghesi, Marco ;
Musi, Gennaro ;
de Cobelli, Ottavio ;
De Berardinis, Ettore .
CLINICAL GENITOURINARY CANCER, 2017, 15 (04) :E661-E666
[8]   Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer [J].
Cantiello, Francesco ;
Russo, Giorgio, I ;
Vartolomei, Mihai Dorin ;
Abu Farhan, Abdal Rahman ;
Terracciano, Daniela ;
Musi, Gennaro ;
Lucarelli, Giuseppe ;
Di Stasi, Savino M. ;
Hurle, Rodolfo ;
Serretta, Vincenzo ;
Busetto, Gian Maria ;
Scafuro, Chiara ;
Perdona, Sisto ;
Borghesi, Marco ;
Schiavina, Riccardo ;
Cioffi, Antonio ;
De Berardinis, Ettore ;
Almeida, Gilberto L. ;
Bove, Pierluigi ;
Lima, Estevao ;
Ucciero, Giuseppe ;
Matei, Deliu Victor ;
Crisan, Nicolae ;
Verzer, Paolo ;
Battaglia, Michele ;
Guazzoni, Giorgio ;
Autorino, Riccardo ;
Morgia, Giuseppe ;
Damiano, Rocco ;
de Cobelli, Ottavio ;
Mirone, Vincenzo ;
Shariat, Shahrokh F. ;
Ferro, Matteo .
EUROPEAN UROLOGY ONCOLOGY, 2018, 1 (05) :403-410
[9]   Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA) [J].
Cao, Rui ;
Yuan, Lushun ;
Ma, Bo ;
Wang, Gang ;
Tian, Ye .
CANCER CELL INTERNATIONAL, 2020, 20 (01)
[10]   Molecular pathways of urothelial development and bladder tumorigenesis [J].
Castillo-Martin, Mireia ;
Domingo-Domenech, Josep ;
Karni-Schmidt, Orit ;
Matos, Tulio ;
Cordon-Cardo, Carlos .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2010, 28 (04) :401-408